Lyophilized Amorphous Dispersion of Telmisartan in a Combined Carrier–Alkalizer System: Formulation Development and In Vivo Study
Main Authors: | Khater A. S. Al-Japairai, Hala M. Alkhalidi, Syed Mahmood, Samah H. Almurisi, Abd Almonem Doolaanea, Taha A. Al-Sindi, Bappaditya Chatterjee |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2020-12-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.0c04588 |
Similar Items
-
Lyophilized amorphous dispersion of telmisartan in a combined carrier–alkalizer system: formulation development and in vivo study
by: Al-Japairai, Khater A. S., et al.
Published: (2020) -
Lyophilized amorphous dispersion of telmisartan in a combined carrier−alkalizer system: formulation development and in vivo study
by: AL-japairai, Khater Ahmed Saeed, et al.
Published: (2020) -
A bioanalytical method for quantification of telmisartan in rat plasma; development, validation and application to pharmacokinetic study
by: AL-japairai, Khater Ahmed Saeed, et al.
Published: (2021) -
Formulation development of paracetamol instant jelly for pediatric use
by: Almurisi, Samah Hamed, et al.
Published: (2020) -
Strategies to improve the stability of amorphous solid dispersions in view of the hot melt extrusion (HME) method
by: AL-japairai, Khater Ahmed Saeed, et al.
Published: (2023)